Page 4 of GlobalData

healthcare revolution, health news, pharma news,

Janssen collaborates with Eli Lilly to address lack of pediatric therapies, could rescue Crohn’s disease drug programme: GlobalData

The agreement between Eli Lilly and Janssen was established to allow the two companies to share resources to accelerate the…

February 6, 2023 11:47 IST

Rare Diseases, healthcare, healthcare news, health news,

Zynerba’s drug could target genetic condition that causes developmental problems but likely to face barrier in uptake: GlobalData

Zygel is anticipated to launch in the US in Q3 2025 and is forecast to generate US sales of $17.9…

February 3, 2023 16:36 IST

Rare Disease Day 2023,World Rare Disease Day,Rare Disease Day 2023 Theme,Rare Disease Day 28 Feb 2023,Rare Disease Day importance, Rare Disease Day

Biomarker identification important for future of chronic inflammatory bowel disease treatment: GlobalData

According to GlobalData, the market for the UC is filled with several different treatment options, and the pipeline is relatively…

January 31, 2023 16:16 IST

Venus Remedies, Cisplatin, healthcare news, pharma news,

With expanded approval for Brukinsa, BeiGene poised to lead leukemia market: GlobalData

In Q3 2022 it earned $1.14 billion in net revenue but that is a 17% drop from the same period…

January 31, 2023 11:33 IST

sexual health, sexual wellness, healthcare news, health news,

Wound care advances with remote monitoring and digital health into 2023: GlobalData

GlobalData claims that monitoring data can also be coupled with AI software to recognize worsening conditions.

January 30, 2023 13:33 IST

GlobalData, pharmaceuticals, vaccines, omicron variants, covid news, China, health news,

Pharma companies that develop vaccines with efficacy against Omicron variants will gain competitive advantage in China: GlobalData

According to GlobalData’s Pharma Intelligence Center,13 homegrown vaccines have been approved for use against COVID-19 in China.

January 25, 2023 14:38 IST

Obesity, Obesity drugs, semaglutide, cancer, cancer treatment, cancer research, healthcare news, pharma news,

89bio’s drug has potential to become a major player in cholesterol disorder market: GlobalData

According to the analyst consensus forecast on the GlobalData Pharma Intelligence Center, the drug is expected to reach $438 million…

January 17, 2023 14:21 IST

GlobalData, Alzheimer's Disease, Leqembi, Eisai, Biogen, Healthcare news, pharma news,

Leqembi’s prospects in Alzheimer’s disease market remain uncertain despite its advantages over Aduhelm: GlobalData

Leqembi is the second anti-Aβ mAb approved by the FDA for the treatment of Alzheimer’s Disease, following the FDA’s controversial…

January 17, 2023 11:19 IST

China, South Korea, and India driving innovation in medical robotics in APAC: GlobalData

Rapid urbanisation and population growth across APAC will increase the number of patients requiring surgical intervention, GlobalData claims.

January 16, 2023 12:49 IST

GlobalData, Cardiomyopathies, cardiac care, healthcare news, pharma news,

Global cardiomyopathies market set to reach $9.63 billion by 2031 driven by US and China’s drug sales: GlobalData

GlobalData also shows that the second highest contributing market in the 68M is the APAC region, generating 33.2% of global…

January 16, 2023 11:54 IST

Genome sequencing solutions will help to bring precision in lung cancer therapy: GlobalData

The LC-SCRUM-AP initiative will screen patients, who have advanced or recurrent non-small cell lung cancer.

January 12, 2023 17:23 IST

GlobalData, cardiovascular diseases, China, Bayer, healthcare news, pharma news,

Western companies to play key role in improving cardiovascular disease management approach in China: GlobalData

Bayer has invested in a new production and supply facility in Beijing to support its CVD and diabetes medicines supply…

January 12, 2023 11:56 IST

GlobalData, genomics, pharmaceutical sector, health news, pharma news,

Genomics identified as most impactful emerging pharma industry trend for 2023: GlobalData survey

The genomics market is expected to exhibit further growth due to rising prevalence of chronic diseases, decreasing sequencing costs, and…

January 11, 2023 17:28 IST

Max Healthcare, Mayo Clinic, cardiac care, healthcare news,

FDA approval for Mobilise rehabilitation device opens doors for investment in health IT-based orthopedic devices in South Korea: GlobalData

GlobalData’s research reveals that South Korea’s orthopedic devices market, which accounts for close to 9 percent of the APAC market…

January 10, 2023 14:10 IST

Artificial Intelligence, AI, healthcare, healthtech, low-cost drugs, healthcare news,

Inflation, drug pricing and reimbursement constraints to have negative impact on biopharmaceutical industry in 2023: GlobalData

The biopharmaceutical industry will be impacted by a number of regulatory and macroeconomic factors in 2023, the data revealed.

January 9, 2023 14:57 IST

Pharmaceuticals, paracetamol, indian pharmaceutical sector, health news, pharma news,

Small molecule approvals for rare diseases in China reach all-time highs this year: GlobalData

In 2020 China established the National Rare Diseases Registry System (NRDRS), which aims to unify rare disease registries into one…

December 16, 2022 12:10 IST

India’s assisted reproductive technology market to record 8% CAGR between 2022 and 2030: GlobalData

Despite growing familiarity and acceptance of a wide range of ART procedures, questions remain about their safety, efficacy, and cost,…

December 15, 2022 18:26 IST

Global pacemakers market set to grow at 5.4% CAGR over next three years: GlobalData

Among pacemakers, dual chamber pacemakers are the fastest growing subsegment, growing at a rate of 5.6 percent, reveals GlobalData.

December 12, 2022 18:24 IST

Related News

Govt extended ITR AY 2025-26 deadline, but only 4.56 crore returns filed so far

SC acts on viral timber log videos in Himachal, sparks political storm

SC takes suo motu cognisance of viral timber log videos, issues notices to Centre, state govts

iPhone 17, iPhone 17 Pro, iPhone 17 Air, iPhone 17 Pro Max colours revealed: Orange, dark blue, purple and more

RBI's CRR Cut to Infuse ₹60,000 Crore, Boosting Banking System Liquidity. (Image Source: Reuters)

First 25-bps CRR cut takes effect today

Who is Phillies’ ‘Karen’? After Polish CEO fiasco, baseball fan berates father-son duo for grabbing home run ball

Go for flexi-cap funds to navigate market volatility

Money15 min ago

Flexi-cap funds are gaining popularity due to their ability to withstand market volatility. In the first half of the year, these funds received Rs 31,500 crore in investments. Their defensive approach helps mitigate risk, while their flexibility allows for diversification and professional management.

View all shorts